Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100® platelet function analyzer

2001 ◽  
Vol 12 (2) ◽  
pp. 85-93 ◽  
Author(s):  
T. F. Slaughter ◽  
G. Sreeram ◽  
A. D. Sharma ◽  
H. El-Moalem ◽  
C. J. East ◽  
...  
2017 ◽  
Vol 44 (2) ◽  
pp. 106-113 ◽  
Author(s):  
Dejana Bogdanic ◽  
Nenad Karanovic ◽  
Jela Mratinovic-Mikulandra ◽  
Branka Paukovic-Sekulic ◽  
Dijana Brnic ◽  
...  

2010 ◽  
Vol 58 (S 01) ◽  
Author(s):  
C Schimmer ◽  
J Moser ◽  
K Hamouda ◽  
SP Sommer ◽  
M Bensch ◽  
...  

2005 ◽  
Vol 123 (5) ◽  
pp. 772-777 ◽  
Author(s):  
Jesús M. Cesar ◽  
Dunia de Miguel ◽  
Angel García Avello ◽  
Carmen Burgaleta

1999 ◽  
Vol 88 (Supplement) ◽  
pp. 16SCA
Author(s):  
GM Sreeram ◽  
A Sharma ◽  
CJ East ◽  
H El-Moalem ◽  
&NA; Greenberg ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-5 ◽  
Author(s):  
Lulu Zhang ◽  
Xiaowei Hu ◽  
Juehua Zhu ◽  
Xiuying Cai ◽  
Yan Kong ◽  
...  

Background. The correlation between platelet function and recurrent ischemic stroke or TIA remains uncertain. Objective. To investigate two inductive agents to detect platelet functions and assess associations with recurrent ischemic stroke/TIA. Method. The study included 738 ischemic stroke/TIA patients. On days 0, 3, and 9 after antiplatelet therapy, platelet function tests were determined by maximum aggregation rate (MAR) using a PL-11 platelet function analyzer and phase matching reagents. Two induction agents were used: arachidonic acid (AA) and adenosine diphosphate (ADP). At 3-month follow-up, recurrence of stroke/TIA was recorded. Result. Cut-off values of adequate platelet function inhibition were MARADP < 35% and MARAA < 35%. Data showed that antiplatelet therapy could reduce the maximum aggregation rate. More importantly, adequate platelet function inhibition of either MARADP or MARAA was not associated with the recurrence of stroke/TIA, but adequate platelet function inhibition of not only MARADP but also MARAA predicts lower recurrence (0/121 (0.00%) versus 18/459 (3.92%), P = 0.0188). Conclusion. The platelet function tested by PL-11 demonstrated that adequate inhibition of both MARADP and MARAA could predict lower risk of ischemic stroke/TIA recurrence.


Sign in / Sign up

Export Citation Format

Share Document